Skip to content

Efficacy and Safety of Oral Cashew Nut Immunotherapy in Children (CAJESITO)

Efficacy and Safety of Oral Cashew Nut Immunotherapy in Children (CAJESITO)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05826405
Acronym
CAJESITO
Enrollment
40
Registered
2023-04-24
Start date
2023-05-10
Completion date
2023-05-10
Last updated
2023-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergy;Food, Allergy, Nut

Keywords

allergy, food allergy, cashew nut allergy, oral immunotherapy, pistachio allergy

Brief summary

The objectives of the CAJESITO study are (i) to assess the tolerance of oral cashew nut immunotherapy, by describing the frequency and severity of allergic reactions during oral cashew nut immunotherapy and (ii )to assess the risk factors for severe allergic reactions during oral cashew nut immunotherapy (predictive factors, associated factors.

Interventions

OTHERNo intervention

No intervention, it's an observational study

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
0 Years to 18 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients under the age of 18 with a proven allergy to cashew nuts and followed in the pediatric allergology unit of the University Hospital of Nancy. * Patients who have received oral cashew nut immunotherapy for at least 18 months as of 02/28/2023

Exclusion criteria

* Patients who have received oral cashew nut immunotherapy for less than 18 months. * Patients lost to follow-up for more than 3 years, i.e. last consultation dating from 2020 or earlier

Design outcomes

Primary

MeasureTime frame
Number of allergic reactionduring 6 months

Secondary

MeasureTime frameDescription
Predictive factor of good toleranceduring 6 monthsage at onset
antibody variationduring 6 monthsModification of level of specific IgE and IGg4 with cashew nuts
sustained unresponsiveness9 monthsTolerance of 1, 2, 4, 8g in isolated doses and 15g in total cumulative dose of cashew nuts during an oral challenge test with cashew nuts 3 months after stopping the daily consumption of 2g of cashew nuts
oral tolerance of pistachio6 monthsTolerance of 1, 2, 4, 8g in isolated doses and 15g in total cumulative dose of pistachio during an oral provocation test with pistachio 3 months after stopping the daily consumption of 2g of cashew nuts

Contacts

Primary ContactAmandine AD DIVARET-CHAUVEAU, MCU PH
a.chauveau@chru-nancy.fr+3383153695

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026